10 May 2024 Blog MHRA issues its first medicinal product approval through the International Recognition Procedure The MHRA has promised a pro-innovation agenda for life sciences. The first approval of a medicinal product through the International Recognition Procedure is a welcome step for industry and patients alike. Share this article Bookmark this page 2 min read
26 February 2024 Insight Making the most of a better climate – biotech M&A in 2024 M&A transactions entered a period of unprecedented activity in 2021. As the era of uncertainty caused by the pandemic started to ease, deal volume and values exceeded expectations across the globe. Bookmark this page 5 min read
13 February 2024 Blog Disparaging the competition? Recent competition law investigations in the life sciences sector highlight the need for caution when making statements about a competitor's products. Share this article Bookmark this page 3 min read
12 February 2024 Insight Partnering, licensing and collaborations - issues and trends Our latest life sciences legal forum focused on partnering, licensing and research collaboration transactions. James Fry and Rebecca Auster addressed current issues and contracting themes from the perspective of reaching the deal, and managing common points of conflict between partners. Bookmark this page 4 min read